Vancouver-based biotech company RepliCel could have the answer to three of the most common signs of growing old: male-pattern baldness, tendon degeneration and ageing skin. The Canadian firm is working on autologous cell therapies – in which the cell donor is also the recipient – which could help reverse or even cure the three conditions. In a study published last week in Nature Communications, researchers at the University of British Columbia found that mice treated with RepliCel’s cells had significantly reduced levels of age-related inflammation markers such as TN@@ Regenerative medicine is a game-changing area with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair," said RepliCel CEO Lee Buckler.
Vancouver-based biotech company RepliCel could have the answer to three of the most common signs of growing old: male-pattern baldness, tendon degeneration and ageing skin. The Canadian firm is working on autologous cell therapies – in which the cell donor is also the recipient – which could help reverse or even cure the three conditions. "Regenerative medicine is a game-changing area with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair," said RepliCel CEO Lee Buckler.